搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
CMAJ
2 天
Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients ...
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...
7 小时
Supplements claiming to work like Ozempic and Wegovy are now being sold – here’s what ...
Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.
11 小时
How to preserve muscle mass on weight-loss drugs like Wegovy
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
Yahoo News
14 小时
Thanksgiving on Ozempic: Here’s how to enjoy the meal with a smaller appetite
GLP-1 (glucagon-like peptide-1) medications reduce appetite by sending signals of fullness to the brain and slowing down ...
Medscape
13 小时
Semaglutide Rocketing Past Statins as Millions Eligible
A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.
6 天
北大校友发现新型神经元,能通过靶向激活快速抑制食欲,或促进司 ...
近日,减重版司美格鲁肽正式在中国上市的消息引起众多关注。提起这种药,就必须提到一种主要由肠道 L 细胞所产生的激素——胰高糖素样肽-1(glucagon-like peptide-1,GLP-1)。该药物正是基于 GLP-1 研发而来。
Medscape
16 小时
GLP-1 Labels Don’t Reflect Trial Exclusions
Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...
21 小时
on MSN
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
News Medical on MSN
7 天
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption
The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
1 天
What's Next for Amgen Obesity Drug After Investors Disappointed by Results
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈